GC Genome was established in August 2013

as a new member of GC Family 

specializing in Clinical Genomics. 

​

Setting itself apart from the other players that only focus on the deciphering of DNA sequences for research purposes, 

GC Genome is moving toward the goal of utilizing genomic information for disease diagnosis, disease screening and also precision medicine. 

​

GC Genome leverages on the most up to date technologies including Next-Generation Sequencing (NGS) to provide distinguished services with shortened turnaround time, and affordable prices. 

Moreover, we continue to invest heavily on R&D activities to develop services to fulfill the unmet needs of people and participate in the advancement of various global and national research projects.

 

Keep an eye out for GC Genome as we develop into a frontier company in genomic diagnostics and we will answer your support with our endless efforts and challenges.  

​

Thank you.